Abbott Laboratories (ABT) total liabilities

Total liabilities · fiscal 2025
$33.94B

Abbott Laboratories (ABT) had total liabilities of $33.94B at the end of fiscal 2025 (December 31, 2025). That is 1.3% higher than the $33.51B of fiscal 2024. Figures as of 18 Nov 2026, 20:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$33.94B
Change on fiscal 2024
+1.3%
Highest on record
$37.53Bfiscal 2022
Lowest on record
$33.51Bfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Abbott Laboratories total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $37.53B in fiscal 2022 and the lowest $33.51B in fiscal 2024.

History · 4 fiscal years

Total liabilities by fiscal year

Abbott Laboratories total liabilities, year by year

Abbott Laboratories (ABT) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$33.94B 1.3% up
2024$33.51B 2.5% down
2023$34.39B 8.4% down
2022$37.53B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Abbott Laboratories and comparable companies
CompanyTotal liabilitiesFiscal year
Gilead Sciences GILD$36.41B2025
Abbott Laboratories ABT$33.94B2025
Novo Nordisk NVODKK 348.86B2025
Pfizer PFE$121.39B2025
Danaher DHR$30.92B2025
Intuitive Surgical ISRG$2.52B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABT

Abbott Laboratories, figure by figure

Abbott Laboratories (ABT) overview: price, valuation and scorecardAll health care companies by market value

Abbott Laboratories total liabilities: questions and answers

How large are Abbott Laboratories's total liabilities?

Abbott Laboratories (ABT) had total liabilities of $33.94B at the end of fiscal 2025 (December 31, 2025). That is 1.3% higher than the $33.51B of fiscal 2024.

What are the highest and lowest total liabilities figures on record for Abbott Laboratories?

Across the 4 fiscal years on record (2022–2025), the highest was $37.53B in fiscal 2022 and the lowest $33.51B in fiscal 2024.

How is Abbott Laboratories's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Abbott Laboratories it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Abbott Laboratories (ABT) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.